MSA is a synucleinopathy, much like dementia with Lewy bodies (DLB) and Parkinson's disease (PD), which is characterized by the pathological presentation of widespread glial cytoplasmic inclusions (GCIs) containing α-synuclein (Cykowski et al., 2015). Here, SNCA is linked to multiple system atrophy.